Brooks Laboratories IPO listing price is ₹ 60.20, issue price is [●], and currently trading at ₹ 136.45 as on May 21, 2025. Brooks Laboratories IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Brooks Laboratories IPO is a Book Building listing on BSE,NSE exchange. The company is based in Punjab and caters to Pharmaceutical sector. D And A Financial Services is the merchant banker of Brooks Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Brooks Laboratories IPO offer price is ₹ 100.00 and got listed at ₹ 60.20. Read Brooks Laboratories IPO details mentioned above.*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Brooks Laboratories IPO, based in Punjab, operates in the Pharmaceutical sector with a focus on business of Pharmaceutical Contract Research & Manufacturing. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Brooks Laboratories IPO size is ₹ 63.00 Cr. Crores with fresh issue size of Rs 63.00 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Brooks Laboratories IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Brooks Laboratories IPO allotment status on the registrars website, Link Intime India Private Limited. Brooks Laboratories IPO refund dates are [●].
Brooks Laboratories IPO is expected to be listed on 5th September 2011.
The upper price band for the Brooks Laboratories IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Brooks Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Brooks Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Brooks Laboratories IPO is finalised.
The merchant banker for Brooks Laboratories IPO is D And A Financial Services Private Limited . D And A Financial Services Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Brooks Laboratories IPO RHP for further details.
The registrar for Brooks Laboratories IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Brooks Laboratories IPO through their official website or helpline.
Brooks Laboratories IPO was subscribed 1.60 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Brooks Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Brooks Laboratories Financial Review Page
Merchant Banker(s) of Brooks Laboratories IPO: D And A Financial Services Private Limited
Brooks Laboratories IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Brooks Laboratories IPO listed at a listing price of 60.20 against the offer price of 100.00.
The current market price of Brooks Laboratories is 136.45.
Why Us?